Subgroup differences in response to 8 weeks of ledipasvir/sofosbuvir for chronic hepatitis C

O'Brien TR, Lang Kuhs KA, Pfeiffer RM. Subgroup differences in response to 8 weeks of ledipasvir/sofosbuvir for chronic hepatitis C. Open Forum Infect Dis. 2014;1(3):ofu110.

Publication Type:

Journal Article

Authors:

O'Brien, Thomas R.; Krystle A. Lang Kuhs; Pfeiffer, Ruth M.

Source:

Open Forum Infect Dis, Volume 1, Issue 3, p.ofu110 (2014)

Keywords:

clinical trial, cost-effectiveness, Direct-acting antiviral agents, gender, hepatitis C virus, IFNL4

Cited On:

External Third-party Web Link:

https://www.ncbi.nlm.nih.gov/pubmed/25734178

Export Citation:
RIS Format
Top